Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 44.50
+0.40 (0.91%)
Mar 27, 2026, 4:08 PM HKT
HKG:6609 Revenue
In the year 2025, Shanghai HeartCare Medical Technology Corporation had annual revenue of 408.29M CNY with 46.92% growth. Shanghai HeartCare Medical Technology Corporation had revenue of 185.52M in the half year ending June 30, 2025, with 69.29% growth.
Revenue
408.29M CNY
Revenue Growth
+46.92%
P/S Ratio
3.71
Revenue / Employee
1.25M CNY
Employees
327
Market Cap
1.68B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 408.29M | 130.39M | 46.92% |
| Dec 31, 2024 | 277.90M | 45.56M | 19.61% |
| Dec 31, 2023 | 232.34M | 49.31M | 26.94% |
| Dec 31, 2022 | 183.03M | 92.94M | 103.17% |
| Dec 31, 2021 | 90.09M | 75.53M | 518.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.71B |
| Gaush Meditech | 1.54B |
| Vincent Medical Holdings | 932.78M |
| Peijia Medical | 793.29M |
| Acotec Scientific Holdings | 717.35M |
| MicroTech Medical (Hangzhou) | 482.95M |
| Venus Medtech (Hangzhou) | 468.17M |
| MicroPort CardioFlow Medtech | 402.73M |